TY  - GEN
AU  - Ratto,G B
AU  - Costa,R
AU  - Maineri,P
AU  - Alloisio,A
AU  - Piras,M T
AU  - D'Agostino,A
AU  - Tripodi,G
AU  - Rivabella,L
AU  - Dozin,B
AU  - Bruzzi,P
AU  - Melioli,G
TI  - Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study
SN  - 0394-6320
PY  - 2012///0302
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - immunology
KW  - Chemotherapy, Adjuvant
KW  - Chi-Square Distribution
KW  - Cisplatin
KW  - administration & dosage
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Immunotherapy
KW  - Interleukin-2
KW  - Italy
KW  - Kaplan-Meier Estimate
KW  - Leukapheresis
KW  - Leukocytes, Mononuclear
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Pilot Projects
KW  - Pneumonectomy
KW  - Proportional Hazards Models
KW  - Recombinant Proteins
KW  - therapeutic use
KW  - Survival Rate
KW  - Time Factors
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1177/039463201102400418
ER  -